Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)Study completedNCT01482221
What this trial is testing

Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 542
Testing effectiveness (Phase 2)Study completedNCT02473289
What this trial is testing

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 193
Testing effectiveness (Phase 2)Ended earlyNCT03093025
What this trial is testing

Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Taisho Pharmaceutical R&D Inc. 51
Not applicableUnknownNCT04428099
What this trial is testing

Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
University of the Balearic Islands 186
Large-scale testing (Phase 3)Ended earlyNCT06514742
What this trial is testing

Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 101
Post-approval studies (Phase 4)WithdrawnNCT05504486
What this trial is testing

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT02943577
What this trial is testing

Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 429
Large-scale testing (Phase 3)Study completedNCT01299272
What this trial is testing

A Study in Prevention of Re-emergence of Depression Symptoms

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 1,249
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)WithdrawnNCT06735079
What this trial is testing

Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
MGGM LLC
Large-scale testing (Phase 3)Study completedNCT00095745
What this trial is testing

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,002
Testing effectiveness (Phase 2)Study completedNCT00840034
What this trial is testing

Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Eli Lilly and Company 227
Large-scale testing (Phase 3)Not Yet RecruitingNCT07775300
What this trial is testing

Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Eli Lilly and Company 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07396272
What this trial is testing

A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression

Who this might be right for
Major Depressive Disorder (MDD)
Daniel Lindqvist 12
Large-scale testing (Phase 3)Ended earlyNCT03610048
What this trial is testing

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Who this might be right for
Refractory Major Depressive Disorder
Alkermes, Inc. 175
Testing effectiveness (Phase 2)Study completedNCT04080752
What this trial is testing

JNJ-61393215 in the Treatment of Depression

Who this might be right for
Major Depressive Disorder With Anxious Distress
Janssen Research & Development, LLC 222
Large-scale testing (Phase 3)Study completedNCT05061706
What this trial is testing

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 480
Large-scale testing (Phase 3)Study completedNCT01942733
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder

Who this might be right for
Sleep Disturbances
H. Lundbeck A/S 44
Large-scale testing (Phase 3)Study completedNCT02196506
What this trial is testing

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 837
Large-scale testing (Phase 3)Study completedNCT03538691
What this trial is testing

A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,149
Next Page